An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
about
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
An Open-Label Phase 1/2 Study ...... ith Non-Small Cell Lung Cancer
@en
type
label
An Open-Label Phase 1/2 Study ...... ith Non-Small Cell Lung Cancer
@en
prefLabel
An Open-Label Phase 1/2 Study ...... ith Non-Small Cell Lung Cancer
@en
P17
P1476
An Open-Label Phase 1/2 Study ...... tic Non-Small Cell Lung Cancer
@en
P3098
NCT02917993
P4844
P580
2016-11-01T00:00:00Z
P582
2020-02-01T00:00:00Z